NF-kappaB inhibitors (Mitsubishi Tanabe Pharma)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNF-kappaB inhibitors (Mitsubishi Tanabe Pharma)
Drug Alias Namenuclear factor-kappaB inhibitors (Mitsubishi Pharma)nuclear factor-kappaB inhibitors (Mitsubishi Tanabe Pharma)NF-kappaB inhibitors (Mitsubishi Pharma)DYA-686
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Tanabe Pharma CorpMitsubishi Pharma Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A